| Q39754105 | A comparison of agency-based and self-report methods of measuring services across an urban environment by a drug-abusing homeless population. |
| Q35723219 | A follow-up study of heroin addicts (VEdeTTE2): study design and protocol |
| Q33716696 | A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers |
| Q37130293 | A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache |
| Q35541054 | Abuse risks and routes of administration of different prescription opioid compounds and formulations |
| Q37798213 | Advanced urine toxicology testing |
| Q37334774 | An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers |
| Q34071216 | Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials |
| Q45327283 | Associations between PTSD and intimate partner and non-partner aggression among substance using veterans in specialty mental health |
| Q44342865 | Behavioral Monitoring and Urine Toxicology Testing in Patients Receiving Long-Term Opioid Therapy |
| Q36021346 | Bridging waitlist delays with interim buprenorphine treatment: initial feasibility |
| Q39688827 | Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment |
| Q42627571 | Comparison Between Urinalysis Results and Self-Reported Heroin Use Among Patients Undergoing Methadone Maintenance Treatment in China |
| Q30805892 | Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients |
| Q35449734 | Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients |
| Q48082354 | Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders |
| Q46895906 | Diagnostic value of self-report of alcohol use in patients enrolled in a methadone maintenance treatment program (MMTP). |
| Q38851643 | Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors |
| Q37185943 | Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. |
| Q34937277 | Distal and proximal factors associated with aggression towards partners and non-partners among patients in substance abuse treatment |
| Q33841530 | Drug use and medication adherence among HIV-1 infected individuals |
| Q57998461 | Embarrassing, degrading, or beneficial: Patient and staff perspectives on urine drug testing in methadone maintenance treatment |
| Q35166154 | Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients |
| Q36980798 | Evaluation of ongoing oxycodone abuse among methadone-maintained patients |
| Q36356899 | HealthCall: technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study |
| Q88098424 | High Agreement Between Benchtop and Point-of-Care Dipcard Tests for Ethyl Glucuronide |
| Q35705286 | High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry |
| Q48700244 | Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program |
| Q44598027 | Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables |
| Q51905895 | Neuropsychological function and employment status in a welfare-to-work sample. |
| Q57069724 | Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests |
| Q37167147 | Partner aggression among men and women in substance use disorder treatment: correlates of psychological and physical aggression and injury |
| Q52305142 | Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. |
| Q51905778 | Screening for alcohol use patterns among methadone maintenance patients. |
| Q35962711 | Substance use disorders in a primary care sample receiving daily opioid therapy |
| Q34992602 | Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis |
| Q35962717 | Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain |
| Q33798275 | The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses with urinalysis |
| Q38223439 | Treatment outcome in substance use disorder patients with and without comorbid posttraumatic stress disorder: A systematic review |
| Q36936152 | Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders |
| Q36463778 | Validity of Self-Reported Drug Use Information Among Pregnant Women |
| Q44839562 | Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence. |
| Q52300054 | Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions. |